arrow
E

Eylem Levelt

Baker Heart and Diabetes Institute
H指数:23
被引数:2,604

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Emerging Role of Glucagon-like Peptide 1 (GLP-1)-Based Medications in the Treatment of Heart Failure, with a Focus on Heart Failure with Preserved or Mildly Reduced Ejection Fraction

胰高血糖素样肽1(GLP-1)基药物在心力衰竭治疗中的新兴作用,重点关注射血分数保留或轻度降低的心力衰竭

2026-05-010
OA
Cardiovascular magnetic resonance to differentiate veteran athlete's heart with cavity dilatation and mild dilated cardiomyopathy

心血管磁共振用于区分有腔室扩张的资深运动员心脏与轻度扩张型心肌病

2025-08-010
PRE
Normal values of high-resolution transmural perfusion distribution metrics for automated quantitative pixel-wise myocardial perfusion CMR

高分辨率透壁灌注分布指标的正常值:用于自动定量像素级心肌灌注CMR

2025-06-190
OAAI
Rheumatoid arthritis is Associated with Sub-Clinical Abnormalities in Myocardial Energetics, Left Ventricular Remodelling, and Increased Fibrosis

类风湿性关节炎与心肌能量代谢的亚临床异常、左心室重构以及纤维化增加相关。

2024-11-120
PRE
Systemic Sclerosis is Associated with Sub-Clinical Abnormalities in Myocardial Energetics, Perfusion and Increased Fibrosis

系统性硬化症与心肌能量代谢、灌注的亚临床异常以及纤维化增加有关。

2024-11-120
PRE
Metformin associates with higher myocardial perfusion reserve and survival in type 2 diabetes mellitus patients
2024-11-081
OAAI
Clinical Significance of Myocardial Injury in Patients Hospitalized for COVID-19 A Prospective, Multicenter, Cohort Study
2024-11-011
OAAI